Gottlieb, P., Delong, T., Baker, R., Fitzgerald-Miller, L., Wagner, R., Cook, G., … Haskins, K. (2014). Chromogranin A is a T cell antigen in human type 1 diabetes. Journal of Autoimmunity, 50, 38-41. https://doi.org/10.1016/j.jaut.2013.10.003 (Original work published 2014)
type 1 diabetes
Sarikonda, G., Pettus, J., Phatak, S., Sachithanantham, S., Miller, J., Wesley, J., … von Herrath, M. (2014). CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes. Journal of Autoimmunity, 50, 77-82. https://doi.org/10.1016/j.jaut.2013.12.003 (Original work published 2014)
Gómez-Touriño, I., Simón-Vázquez, R., Alonso-Lorenzo, J., Arif, S., Calviño-Sampedro, C., González-Fernández, Á., … Varela-Calvino, R. (2015). Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes. Clinical and Experimental Immunology, 180(2), 207-17. https://doi.org/10.1111/cei.12572 (Original work published 2015)
Besançon, A., Goncalves, T., Valette, F., Dahllöf, M., Mandrup-Poulsen, T., Chatenoud, L., & You, S. (2018). Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice. Diabetologia, 61(2), 389-398. https://doi.org/10.1007/s00125-017-4459-0 (Original work published 2018)
Xian, Y., Xu, H., Gao, Y., Yan, J., Lv, J., Ren, W., … Weng, J. (2020). A pilot study of preproinsulin peptides reactivity in Chinese patients with type 1 diabetes. Diabetes/Metabolism/Research/and/Reviews, 36(2), e3228. https://doi.org/10.1002/dmrr.3228 (Original work published 2020)
Luce, S. (2021). A Humanized Mouse Strain That Develops Spontaneously Immune-Mediated Diabetes. Frontiers in Immunology, 12, 748679. https://doi.org/10.3389/fimmu.2021.748679 (Original work published 2021)
Foray, A.-P., Candon, S., Hildebrand, S., Marquet, C., Valette, F., Pecquet, C., … Chatenoud, L. (2021). De novo germline mutation in the dual specificity phosphatase 10 gene accelerates autoimmune diabetes. Proceedings of the National Academy of Sciences of the United States of America, 118(47). https://doi.org/10.1073/pnas.2112032118 (Original work published 2021)
Arif, S., Pujol-Autonell, I., Kamra, Y., Williams, E., Yusuf, N., Domingo-Vila, C., … Lorenc, A. (2021). Mapping T Cell Responses to Native and Neo-Islet Antigen Epitopes in at Risk and Type 1 Diabetes Subjects. Frontiers in Immunology, 12, 675746. https://doi.org/10.3389/fimmu.2021.675746 (Original work published 2021)
Arif, S., Yusuf, N., Domingo-Vila, C., Liu, Y.-F., Bingley, P., & Peakman, M. (2022). Evaluating T cell responses prior to the onset of type 1 diabetes. Diabetic Medicine : A Journal of the British Diabetic Association, 39(9), e14860. https://doi.org/10.1111/dme.14860 (Original work published 2022)
Bessard, M.-A., Moser, A., Waeckel-Énée, E., Lindo, V., Gdoura, A., You, S., … van Endert, P. (2024). Insulin-degrading enzyme regulates insulin-directed cellular autoimmunity in murine type 1 diabetes. Frontiers in Immunology, 15, 1474453. https://doi.org/10.3389/fimmu.2024.1474453 (Original work published 2024)